New 30-Day Treatment for Chagas Disease Shows Promise

Just now September 23, 2026 1 min read 📰 Medical Xpress

📋 Key Takeaway

A new 30-day treatment for Chagas disease using benznidazole has been found to be safer and more practical than the current 60-day regimen. The TESEO trial, co-led by institutions from Spain, the U.S., and Bolivia, highlights advancements in treating chronic infections. This development could influence healthcare strategies in Iran, particularly in managing infectious diseases.

A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days. The results of the TESEO trial, co-led by the Barcelona Institute for Global Health (ISGlobal), the University of Texas at El Paso (UTEP, U.S.), and CEADES (Bolivia), are published in The Lancet Infectious Diseases.